Posts

Showing posts from April, 2020

Global Hand Sanitizer Spray Market Precise Outlook From 2020-2024

Apr 08, 2020:  In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market.  Hand Sanitizer Spray Report  by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Hand Sanitizer Spray market is valued at USD XX million in 2020 and is projected to reach USD XX million by the end of 2024, growing at a CAGR of XX% during the period 2020 to 2024. To Request A Sample Copy Of This Report @:     https://www.radiantinsights.com/research/global-hand-sanitizer-spray-market-research-report-2020-2024/request-sample The report firstly introduced the Hand Sanitizer Spray basics: definitions, classifications, applications and

Antimalarial Drug Market Growing Popularity And Emerging Trends As A Effective To Reduce COVID 19 Symptoms

Apr 07, 2020:  The global  Antimalarial Drug market  was valued at $XX million in 2017, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. Indian and worldwide pharma companies stepped up the production of Hydroxychloroquine sulfate Antimalarial medicines which shows the effectiveness against the coronavirus by the recent study result by International Journal of Antimicrobial Agents. This drugs reduce the symptoms of virus by huge margin, it is tested on the patients in France and China. In China they mostly used chloroquine for treatment. Companies like Teva, Mylan, Amneal are ready to distribute the HCQs drugs which is mostly used for the malaria, rheumatoid arthritis and lupus. Recent news shows shortage of HCQS in USA, India Lifted the export ban of HCQS to the countries which are mostly affected by coronavirus (COVID 19). Latest trial conducted in France Clinic shows th